Towards a Solution Space for BPM Issues Based on Debiasing Techniques

M. Razavian,Irene T. P. Vanderfeesten,O. Türetken

DOI: https://doi.org/10.1007/978-3-319-74030-0_29

2017-09-10

Abstract:

What problem does this paper attempt to address?

Acute kidney injury in the critically ill: an updated review on pathophysiology and management

Peter Pickkers,Michael Darmon,Eric Hoste,Michael Joannidis,Matthieu Legrand,Marlies Ostermann,John R. Prowle,Antoine Schneider,Miet Schetz

DOI: https://doi.org/10.1007/s00134-021-06454-7

IF: 38.9

2021-07-02

Intensive Care Medicine

Abstract:Acute kidney injury (AKI) is now recognized as a heterogeneous syndrome that not only affects acute morbidity and mortality, but also a patient's long-term prognosis. In this narrative review, an update on various aspects of AKI in critically ill patients will be provided. Focus will be on prediction and early detection of AKI (e.g., the role of biomarkers to identify high-risk patients and the use of machine learning to predict AKI), aspects of pathophysiology and progress in the recognition of different phenotypes of AKI, as well as an update on nephrotoxicity and organ cross-talk. In addition, prevention of AKI (focusing on fluid management, kidney perfusion pressure, and the choice of vasopressor) and supportive treatment of AKI is discussed. Finally, post-AKI risk of long-term sequelae including incident or progression of chronic kidney disease, cardiovascular events and mortality, will be addressed.

critical care medicine
Rhabdomyolysis and brain ischemic stroke in a heroin‐dependent male under methadone maintenance therapy

W. Hsu,N. Chiu,Yi-Chen Liao

DOI: https://doi.org/10.1111/j.1600-0447.2009.01378.x

2009-07-01

Acta Psychiatrica Scandinavica

Abstract:Objective: There are several complications associated with heroin abuse, some of which are life‐threatening. Methadone may aggravate this problem.
Acute kidney injury in dogs and cats 1. Pathogenesis and diagnosis

Adam Mugford,Ronald Li,Karen Humm

DOI: https://doi.org/10.1136/inp.f2868

2013-05-01

In Practice

Abstract:Acute kidney injury (AKI), an abrupt loss of renal function, is a commonly encountered emergency in small animal practice. This article, the first of two on AKI, reviews the pathophysiology and diagnosis of the condition in dogs and cats. The second article, to be published in the June issue of In Practice , will cover the treatment, recovery and prognosis associated with AKI.

veterinary sciences
International Renal Interest Society best practice consensus guidelines for the diagnosis and management of acute kidney injury in cats and dogs

Gilad Segev,Stefano Cortellini,Jonathan D Foster,Thierry Francey,Catherine Langston,Leonel Londoño,Ariane Schweighauser,Rosanne E Jepson

DOI: https://doi.org/10.1016/j.tvjl.2024.106068

Abstract:Acute kidney injury (AKI) is defined as an injury to the renal parenchyma, with or without a decrease in kidney function, as reflected by accumulation of uremic toxins or altered urine production (i.e., increased or decreased). AKI might result from any of several factors, including ischemia, inflammation, nephrotoxins, and infectious diseases. AKI can be community- or hospital-acquired. The latter was not previously considered a common cause for AKI in animals; however, recent evidence suggests that the prevalence of hospital-acquired AKI is increasing in veterinary medicine. This is likely due to a combination of increased recognition and awareness of AKI, as well as increased treatment intensity (e.g., ventilation and prolonged hospitalization) in some veterinary patients and increased management of geriatric veterinary patients with multiple comorbidities. Advancements in the management of AKI, including the increased availability of renal replacement therapies, have been made; however, the overall mortality of animals with AKI remains high. Despite the high prevalence of AKI and the high mortality rate, the body of evidence regarding the diagnosis and the management of AKI in veterinary medicine is very limited. Consequently, the International Renal Interest Society (IRIS) constructed a working group to provide guidelines for animals with AKI. Recommendations are based on the available literature and the clinical experience of the members of the working group and reflect consensus of opinion. Fifty statements were generated and were voted on in all aspects of AKI and explanatory text can be found either before or after each statement.
Biomarkers, Diagnosis and Management of Sepsis-Induced Acute Kidney Injury: a Narrative Review.

Zhongheng Zhang

2015-01-01

Abstract:Sepsis is a leading cause of acute kidney injury in clinical practice. The diagnosis of sepsis-induced acute kidney injury requires the diagnosis of sepsis and subsequent occurrence of acute kidney injury. The current definition for acute kidney injury is based on Scr and urine output, which is limited by the delayed identification of such patients. Numerous novel biomarkers have been found to be up-regulated in kidney injury, among which cystatin C and neutrophil gelatinase-associated lipocalin are the most studied. In the management of sepsis-induced acute kidney injury, early goal directed therapy may be potentially useful, but requires further validation in large clinical trials. It is well known that fluid overload is harmful in septic patients with established acute kidney injury and should be avoided. Renal replacement therapy is the mainstay treatment for the severe form of sepsis-induced acute kidney injury. However, there is still no consensus on the definition of timing and dosing in clinical practice, and the optimal timing and dosing are still unknown.
Management of patients at risk of acute kidney injury

Jill Vanmassenhove,Jan Kielstein,Achim Jörres,Wim Van Biesen

DOI: https://doi.org/10.1016/S0140-6736(17)31329-6

2017-05-27

Abstract:Acute kidney injury (AKI) is a multifaceted syndrome that occurs in different settings. The course of AKI can be variable, from single hit and complete recovery, to multiple hits resulting in end-stage renal disease. No interventions to improve outcomes of established AKI have yet been developed, so prevention and early diagnosis are key. Awareness campaigns and education for health-care professionals on diagnosis and management of AKI-with attention to avoidance of volume depletion, hypotension, and nephrotoxic interventions-coupled with electronic early warning systems where available can improve outcomes. Biomarker-based strategies have not shown improvements in outcome. Fluid management should aim for early, rapid restoration of circulatory volume, but should be more limited after the first 24-48 h to avoid volume overload. Use of balanced crystalloid solutions versus normal saline remains controversial. Renal replacement therapy should only be started on the basis of hard criteria, but should not be delayed when criteria are met. On the basis of recent evidence, the risk of contrast-induced AKI might be overestimated for many conditions.
Kidney Disease Models: Tools to Identify Mechanisms and Potential Therapeutic Targets

Yin-Wu Bao,Yuan,Jiang-Hua Chen,Wei-Qiang Lin

DOI: https://doi.org/10.24272/j.issn.2095-8137.2017.055

2018-01-01

Zoological Research

Abstract:Acute kidney injury (AKI) and chronic kidney disease (CKD) are worldwide public health problems affecting millions of people and have rapidly increased in prevalence in recent years. Due to the multiple causes of renal failure, many animal models have been developed to advance our understanding of human nephropathy. Among these experimental models, rodents have been extensively used to enable mechanistic understanding of kidney disease induction and progression, as well as to identify potential targets for therapy. In this review, we discuss AKI models induced by surgical operation and drugs or toxins, as well as a variety of CKD models (mainly genetically modified mouse models). Results from recent and ongoing clinical trials and conceptual advances derived from animal models are also explored.
Pathophysiology of Acute Kidney Injury in Critical Illness: A Narrative Review

Luis A Juncos,Patrick M Wieruszewski,Kianoush Kashani

DOI: https://doi.org/10.1002/cphy.c210028

2022-09-08

Abstract:Acute kidney injury (AKI) is a syndrome that entails a rapid decline in kidney function with or without injury. The consequences of AKI among acutely ill patients are dire and lead to higher mortality, morbidity, and healthcare cost. To prevent AKI and its short and long-term repercussions, understanding its pathophysiology is essential. Depending on the baseline kidney histology and function reserves, the number of kidney insults, and the intensity of each insult, the clinical presentation of AKI may differ. While many factors are capable of inducing renal injury, they can be categorized into a few processes. The three primary processes reported in the literature are hemodynamic changes, inflammatory reactions, and nephrotoxicity. The majority of patients with AKI will suffer from more than one during their development and/or progression of AKI. Moreover, the development of one usually leads to the instigation of another. Thus, the interactions and progression between these mechanisms may determine the severity and duration of the AKI. Other factors such as organ crosstalk and how our concurrent therapies interact with these mechanisms complicate the pathophysiology of the progression of the AKI even further. In this narrative review article, we describe these three main pathophysiological processes that lead to the development and progression of AKI. © 2022 American Physiological Society. Compr Physiol 12: 1-14, 2022.
[Acute Kidney Injury: Epidemiology, Pathophysiology, Repair Mechanisms].

T. Dimski,D. Kindgen-Milles,T. Brandenburger

DOI: https://doi.org/10.1055/a-1105-0587

2021-02-01

Abstract:Acute kidney injury (AKI) is a major complication in critically ill patients and affects up to 50% of those admitted to intensive care units. Causes of AKI include patient specific factors (susceptibility: e.g. age, pre-existing chronic kidney disease, chronic heart failure, diabetes) and patient unspecific factors (exposure: e.g. sepsis, hypovolemia, cardiac surgery, nephrotoxin application). Mortality of severe AKI is in the range of 40 - 50%.AKI is accompanied by volume overload, electrolyte disorders, acidosis, and uremia. The diagnosis of AKI is based on an increase of creatinine levels and/or a decrease in urine output within 7 days after an insult. These 2 markers are late und unspecific, especially with regard to early identification of patients at risk of AKI. New AKI markers have been investigated within the last decade including NGAL (neutrophil gelatinase-associated lipocalin), the product of IGFBP-7 (insulin like growth factor binding protein 7) and TIMP-2 (tissue inhibitor of metalloproteinase 2), KIM-1 (kidney injury molecule 1) and the cysteine-protease-inhibitor cystatin C. New markers or a panel of new markers might improve the diagnosis of patients at risk of AKI in the future.There are currently no specific therapeutics in the treatment of AKI. Therefore, the prevention of AKI is of an utmost importance. The recommended preventive measures include optimization of hemodynamics and volume status, close monitoring of creatinine levels and urine output, avoidance or discontinuation of nephrotoxic drugs, normoglycemia and the application of alternatives to radiocontrast agents if possible.As the long term prognosis of AKI highly depends on renal recovery, the 2 major goals for the future will be 1) the early identification of patients at AKI risk and 2) the support of renal recovery of AKI patients.

Medicine
Biomarkers for Early Diagnosis of Acute Kidney Injury: Current Progress and Clinical prospects.

Hong-Feng Huang,Jing-Yi Zhou,Jiang-Hua Chen

DOI: https://doi.org/10.2174/1389203717666160909152205

2017-01-01

Abstract:Acute kidney injury (AKI) is one of the most common complications in critically ill patients, resulting in high morbidity and mortality. AKI usually occurs after major surgery, severe infection or drug-induced nephrotoxicity and is associated with prolonged hospital stays, increased costs and adverse clinical outcomes. The diagnosis of AKI is currently based on decreased glomerular filtration rate (GFR) and urine output, and increased serum creatinine. Novel biomarkers are required for early identification of patients with AKI to allow timely therapy and improve patient outcomes. With the advent of proteomics and genomics techniques, a vast array of biomarkers are now available in clinical practice.
Letter by Khan and Moukarbel regarding article, "Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study".

Abdur Rahman Khan,G. Moukarbel

DOI: https://doi.org/10.1161/CIRCULATIONAHA.114.009621

IF: 37.8

2015-01-06

Circulation

Abstract:We read with interest the article by Dalager-Pedersen and colleagues1 on the risk of myocardial infarction and stroke in community-acquired bacteremia. In this population-based cohort study, the authors found higher incident events of myocardial infarction and stroke within a year of admission for community-acquired bacteremia …
[Carboxylic proteinases from the microscopic fungi Trichoderma viride and Trichoderma lignorum].

A. V. Gaida,A. Osterman,G. N. Rudenskaia,V. Stepanov

Биохимия

Abstract:Using ion-exchange chromatography on aminosilochrome and biospecific chromatography on Bacitracin-Sepharose, the carboxylic proteinases have been isolated for the first time from the microscopic fungi of the Trichoderma genus -- Trichoderma viride and Trichoderma lignorum, commonly used to produce cellulases. The proteinases are stable within the pH range of 3 to 6; pI is 4,3 and 4,5, the pH optimum -- 2,3 and 2,8, respectively. The molecular weight of the enzymes is 32000, the amino acid composition of T. viride proteinase is Lys5His2Arg6Asx27Thr39Ser38Glx27Pro13..Gly41Ala28Cys2Val37Ile11Leu17Tyr13Phe11Trp3, that of T. lignorum is Lys9His4Arg6Asx36Thr26Ser46Glx25Pro14Gly35Ala23Cys2Val28Ile26Leu19Tyr12..Phe14Trp4. Both enzymes are completely inactivated by specific inhibitors of carboxylic proteinase, i. e. pepstatin, diazoacetyl-D,L-norvaline methylester and N-diazoacetyl-N'-2,4-dinitrophenylethylenediamine. The molecular and enzymatic properties of the proteinases under study are close to those of carboxylic proteinases of microscopic fungi and in a lesser degree to those of porcine pepsin.
Diagnostic work-up and specific causes of acute kidney injury

Michael Darmon,Marlies Ostermann,Jorge Cerda,Meletios A. Dimopoulos,Lui Forni,Eric Hoste,Matthieu Legrand,Nicolas Lerolle,Eric Rondeau,Antoine Schneider,Bertrand Souweine,Miet Schetz

DOI: https://doi.org/10.1007/s00134-017-4799-8

IF: 38.9

2017-04-25

Intensive Care Medicine

Abstract:Acute kidney injury (AKI) is common in critically ill patients and associated with grim short- and long-term outcome. Although in the vast majority of cases AKI is multifactorial, with sepsis, shock and nephrotoxicity accounting for most episodes, specific causes of AKI are not uncommon. Despite remaining uncertainties regarding their prevalence in the ICU, prompt recognition of specific aetiologies of AKI is likely to ensure timely management, limit worsening of renal dysfunction, and ultimately limit renal and systemic consequences of AKI. The ability to recognize conditions that may be associated with specific aetiologies and the appropriate use of clinical imaging, biological and immunological tests, along with optimal assessment of the need for renal biopsies, should be part of routine ICU care. In this review, we summarize uncertainties, current knowledge and recent advances regarding specific types of AKI. We describe the most common specific causes as well as rare aetiologies requiring urgent management, and outline available tools that may be used during the diagnostic work-up along with their limitations.

critical care medicine
Pathophysiology and treatment of kidney disease in cats

Amy Breton

DOI: https://doi.org/10.12968/vetn.2012.3.10.600

2012-12-01

The Veterinary Nurse

Abstract:Kidneys are responsible for the regulation of the body’s water, electrolyte and acid-base balance as well as excretion of metabolic waste products and foreign chemicals, glucose synthesis and erythropoietin production. Although kidney failure is a common disease affecting feline patients, an increased understanding of the disease and advances in treatment mean that cats are living longer after diagnosis. Renal disease can be acute or chronic, and is hallmarked by an elevated blood urea nitrogen and serum creatinine (azotaemia). It is important that cats with kidney failure receive a complete diagnostic work-up in order to determine the underlying cause; tailored treatment includes fluid therapy, correcting acid-base and electrolyte abnormalities, treating hypertension and anaemia, renal transplantation, intermittent haemodialysis and continuous renal replacement therapy.
Acute Kidney Injury in Patients with Chronic Liver Disease: A Review

Hilary A. Elom,Yassmin Hegazy,Edgar V Lerma,Mohamed Hassanein

DOI: https://doi.org/10.25259/ijn_333_23

2024-06-24

Indian Journal of Nephrology

Abstract:Introduction: Acute kidney injury (AKI) is a frequent complication of chronic liver disease (CLD) contributing to high morbidity and mortality worldwide. While liver transplantation (LT) has shown favorable outcomes, early identification and management of AKI is imperative for survival. This review aims to highlight the epidemiology, pathophysiology, management, and prognosis of AKI in CLD. Methods: An extensive literature search was performed using PubMed, Medline, and Google Scholar to identify literature related to epidemiology, burden, clinical presentations, prognosis, and management of AKI in CLD. Results: The identified studies highlighted a wide range of prevalence of AKI in hospitalized patients with CLD. The etiology and pathophysiology are multifactorial and include prerenal AKI, acute tubular injury, sepsis, gastrointestinal bleeding, bacterial translocation from the gut, and hepatorenal syndrome (HRS). AKI is associated with a higher risk of morbidity and mortality and progression to chronic kidney disease following LT. Management of AKI in CLD varies based on the underlying etiology. While vasoconstrictors like terlipressin have shown great potential in the treatment of HRS-AKI and is widely used in Europe and United States, LT remains the definitive therapy of choice. In most cases, kidney replacement therapy serves as a bridge to liver transplant. Conclusion: AKI is a serious complication of CLD and early identification is essential. Diagnosis and management, particularly HRS is challenging and requires a high index of suspicion. More research is required to identify novel therapies to improve outcomes of AKI in patients with CLD.
Currently Used Methods to Evaluate the Efficacy of Therapeutic Drugs and Kidney Safety

Hung-Jin Huang,Chu-Lin Chou,Tin Sandar,Wen-Chih Liu,Hsiu-Chien Yang,Yen-Chung Lin,Cai-Mei Zheng,Hui-Wen Chiu,Tin Tin Sandar

DOI: https://doi.org/10.3390/biom13111581

IF: 6.064

2023-10-27

Biomolecules

Abstract:Kidney diseases with kidney failure or damage, such as chronic kidney disease (CKD) and acute kidney injury (AKI), are common clinical problems worldwide and have rapidly increased in prevalence, affecting millions of people in recent decades. A series of novel diagnostic or predictive biomarkers have been discovered over the past decade, enhancing the investigation of renal dysfunction in preclinical studies and clinical risk assessment for humans. Since multiple causes lead to renal failure, animal studies have been extensively used to identify specific disease biomarkers for understanding the potential targets and nephropathy events in therapeutic insights into disease progression. Mice are the most commonly used model to investigate the mechanism of human nephropathy, and the current alternative methods, including in vitro and in silico models, can offer quicker, cheaper, and more effective methods to avoid or reduce the unethical procedures of animal usage. This review provides modern approaches, including animal and nonanimal assays, that can be applied to study chronic nonclinical safety. These specific situations could be utilized in nonclinical or clinical drug development to provide information on kidney disease.

biochemistry & molecular biology
Lessons learned from kidney dysfunction : Preventing organ failure

Stefan John

DOI: https://doi.org/10.1007/s00063-020-00659-2

Abstract:Background: Acute kidney injury (AKI) is a common and severe complication in patients in the intensive care unit with a significant impact on patient's mortality and morbidity. Therefore renal protective therapy is very important in these severely ill patients. Aim: Several renal protective strategies have been postulated during recent decades, which came from pathophysiologic concepts and have been contradicted or changed during the last few years. So lessons had to be learned in AKI, leading to new, in many cases completely reversed preventive and therapeutic concepts which may also be important for protection in other organs. Recent findings: Most important for renal protection is the early identification of patients at risk for AKI or with acute kidney damage before renal function further deteriorates. A stage-based management of AKI comprises more general measures like discontinuation of the nephrotoxic agent but most importantly early hemodynamic stabilization. Recent research has contradicted that AKI is renal ischemia caused by vasoconstriction with consecutive tubular necrosis. In septic AKI, renal blood flow is even increased. Intrarenal vasodilation together with microcirculatory changes and redistribution of blood flow lead to a drop in glomerular filtration by functional changes. Accordingly it had to be learned that not vasodilators but vasoconstrictors are beneficial in AKI. A mean arterial blood pressure target of >65 mm Hg is often recommended but exact targets are not known, and patients with pre-existing hypertension even need higher perfusion pressure. Also the concept that fluid therapy is always beneficial for the kidney in shock states had to be revised. A volume restrictive therapy with only balanced crystalloids is also becoming more important in AKI. Still no specific pharmacological therapy for renal protection is available. Inflammation and mitochondrial dysfunction appear to play a significant role in AKI. Anti-inflammatory strategies are under investigation and may become more important for AKI prevention and therapy in the future. (This article is freely available.).
Acute kidney injury in the acute care surgery patient: What you need to know

Cassandra V Villegas,Elizabeth Gorman,Frank M Liu,Robert J Winchell

DOI: https://doi.org/10.1097/TA.0000000000004401

2024-09-06

Abstract:Acute kidney injury is associated with poor outcomes in the trauma and emergency general surgery population, and recent consensus definitions have allowed for significant advances in defining the burden of disease. The current definitions rely on overall functional measures (i.e., serum creatinine and urine output), which can be confounded by a variety of clinical factors. Biomarkers are increasingly being investigated as more direct diagnostic assays for the diagnosis of acute kidney injury and may allow earlier detection and more timely therapeutic intervention. Etiologies fall into two general categories: disorders of renal perfusion and exposure to nephrotoxic agents. Therapy is largely supportive, and prevention offers the best chance to decrease clinical impact.
Perioperative Acute Kidney Injury: An Under-recognized Problem.

A. Zarbock,C. Schmidt,M. Meersch

DOI: https://doi.org/10.1213/ANE.0000000000002369

2017-10-01

Abstract:The incidence of perioperative acute kidney injury (AKI) is more common than previously recognized, especially in high-risk patients undergoing higher risk procedures. The growing number of patients who develop perioperative AKI is related, in part, to the aging population and increase in the number of individuals with chronic comorbidities, particularly those with premorbid chronic kidney disease. Despite the acceptance of standardization in the definition of AKI, clinicians routinely underdiagnose it and fail to appreciate that it is associated with considerable morbidity and mortality. Unfortunately, few, if any, preemptive therapies have proven effective in preventing AKI. Timely diagnostic methods using evolving biomarkers raises the prospect of detection of kidney damage before the onset of irreversible loss of function, but remain under investigation. Clear evidence supporting any therapeutic intervention except renal replacement therapy remains elusive. Renal replacement therapy is indicated for select patients with progressive AKI; however, the ideal timing, method, and application of it remain under debate. It is fundamental to identify patients at risk for AKI. The Kidney Disease: Improving Global Outcomes guidelines suggest preventive strategies that include avoidance of nephrotoxic agents and hyperglycemia, optimization of hemodynamics, restoration of the circulating volume, and institution of functional hemodynamic monitoring. Clear evidence in support of this approach, however, is lacking. Recently, the perioperative administration of dexmedetomidine and the provision of remote ischemic preconditioning have been studied to potentially limit the development of perioperative AKI. This review discusses accepted standard definitions of AKI, highlights associated risk factors for its development, and provides an overview of its epidemiology and pathology. It emphasizes potential preventive strategies, the possible role of emerging biomarkers in defining its presence more expeditiously before irreversible injury, and current recommended guidelines and therapeutic approaches. The ultimate goal of this article is to bring to the attention of clinicians the seriousness of this potentially preventable or modifiable perioperative complication.

Medicine
SU-E-T-599: The Variation of Hounsfield Unit and Relative Electron Density Determination as a Function of KVp and Its Effect On Dose Calculation Accuracy.

A. Ohl,S De Boer

DOI: https://doi.org/10.1118/1.4888935

2014-06-01

Abstract:PURPOSE To investigate the differences in relative electron density for different energy (kVp) settings and the effect that these differences have on dose calculations. METHODS A Nuclear Associates 76-430 Mini CT QC Phantom with materials of known relative electron densities was imaged by one multi-slice (16) and one single-slice computed tomography (CT) scanner. The Hounsfield unit (HU) was recorded for each material with energies ranging from 80 to 140 kVp and a representative relative electron density (RED) curve was created. A 5 cm thick inhomogeneity was created in the treatment planning system (TPS) image at a depth of 5 cm. The inhomogeneity was assigned HU for various materials for each kVp calibration curve. The dose was then calculated with the analytical anisotropic algorithm (AAA) at points within and below the inhomogeneity and compared using the 80 kVp beam as a baseline. RESULTS The differences in RED values as a function of kVp showed the largest variations of 580 and 547 HU for the Aluminum and Bone materials; the smallest differences of 0.6 and 3.0 HU were observed for the air and lung inhomogeneities. The corresponding dose calculations for the different RED values assigned to the 5 cm thick slab revealed the largest differences inside the aluminum and bone inhomogeneities of 2.2 to 6.4% and 4.3 to 7.0% respectively. The dose differences beyond these two inhomogeneities were between 0.4 to 1.6% for aluminum and 1.9 to 2.2 % for bone. For materials with lower HU the calculated dose differences were less than 1.0%. CONCLUSION For high CT number materials the dose differences in the phantom calculation as high as 7.0% are significant. This result may indicate that implementing energy specific RED curves can increase dose calculation accuracy.

Towards a Solution Space for BPM Issues Based on Debiasing Techniques

Acute kidney injury in the critically ill: an updated review on pathophysiology and management

Rhabdomyolysis and brain ischemic stroke in a heroin‐dependent male under methadone maintenance therapy

Acute kidney injury in dogs and cats 1. Pathogenesis and diagnosis

International Renal Interest Society best practice consensus guidelines for the diagnosis and management of acute kidney injury in cats and dogs

Biomarkers, Diagnosis and Management of Sepsis-Induced Acute Kidney Injury: a Narrative Review.

Management of patients at risk of acute kidney injury

Kidney Disease Models: Tools to Identify Mechanisms and Potential Therapeutic Targets

Pathophysiology of Acute Kidney Injury in Critical Illness: A Narrative Review

[Acute Kidney Injury: Epidemiology, Pathophysiology, Repair Mechanisms].

Biomarkers for Early Diagnosis of Acute Kidney Injury: Current Progress and Clinical prospects.

Letter by Khan and Moukarbel regarding article, "Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study".

[Carboxylic proteinases from the microscopic fungi Trichoderma viride and Trichoderma lignorum].

Diagnostic work-up and specific causes of acute kidney injury

Pathophysiology and treatment of kidney disease in cats

Acute Kidney Injury in Patients with Chronic Liver Disease: A Review

Currently Used Methods to Evaluate the Efficacy of Therapeutic Drugs and Kidney Safety

Lessons learned from kidney dysfunction : Preventing organ failure

Acute kidney injury in the acute care surgery patient: What you need to know

Perioperative Acute Kidney Injury: An Under-recognized Problem.

SU-E-T-599: The Variation of Hounsfield Unit and Relative Electron Density Determination as a Function of KVp and Its Effect On Dose Calculation Accuracy.